BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15481152)

  • 21. Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.
    Seno A; Maruhashi T; Kaifu T; Yabe R; Fujikado N; Ma G; Ikarashi T; Kakuta S; Iwakura Y
    Exp Anim; 2015; 64(2):109-19. PubMed ID: 26176030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway.
    Lambert AA; Barabé F; Gilbert C; Tremblay MJ
    Blood; 2011 Jun; 117(24):6589-99. PubMed ID: 21536857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor.
    Ronninger M; Eklöw C; Lorentzen JC; Klareskog L; Padyukov L
    Genes Immun; 2008 Jul; 9(5):412-8. PubMed ID: 18480830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and characterization of a novel ITIM containing lectin-like immunoreceptor LLIR and its two transmembrane region deletion variants.
    Huang X; Yuan Z; Chen G; Zhang M; Zhang W; Yu Y; Cao X
    Biochem Biophys Res Commun; 2001 Feb; 281(1):131-40. PubMed ID: 11178971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
    Jähn PS; Zänker KS; Schmitz J; Dzionek A
    Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors.
    Lambert AA; Azzi A; Lin SX; Allaire G; St-Gelais KP; Tremblay MJ; Gilbert C
    PLoS One; 2013; 8(7):e67873. PubMed ID: 23874461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells.
    Heidkamp GF; Neubert K; Haertel E; Nimmerjahn F; Nussenzweig MC; Dudziak D
    Immunol Lett; 2010 Aug; 132(1-2):69-78. PubMed ID: 20566350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of Mycobacteria by Dendritic Cell Immunoactivating Receptor.
    Toyonaga K; Yamasaki S
    Curr Top Microbiol Immunol; 2020; 429():103-115. PubMed ID: 32300915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways.
    Lambert AA; Gilbert C; Richard M; Beaulieu AD; Tremblay MJ
    Blood; 2008 Aug; 112(4):1299-307. PubMed ID: 18541725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human NKG2F is expressed and can associate with DAP12.
    Kim DK; Kabat J; Borrego F; Sanni TB; You CH; Coligan JE
    Mol Immunol; 2004 May; 41(1):53-62. PubMed ID: 15140575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
    Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
    J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C-type lectin receptor DCIR is crucial for the development of experimental cerebral malaria.
    Maglinao M; Klopfleisch R; Seeberger PH; Lepenies B
    J Immunol; 2013 Sep; 191(5):2551-9. PubMed ID: 23918990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
    Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells.
    Fujikado N; Saijo S; Yonezawa T; Shimamori K; Ishii A; Sugai S; Kotaki H; Sudo K; Nose M; Iwakura Y
    Nat Med; 2008 Feb; 14(2):176-80. PubMed ID: 18204462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing immune responses by targeting antigen to DC.
    Caminschi I; Lahoud MH; Shortman K
    Eur J Immunol; 2009 Apr; 39(4):931-8. PubMed ID: 19197943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
    Daëron M; Jaeger S; Du Pasquier L; Vivier E
    Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.